1
|
Alcohol and environmental justice: the density of liquor stores and bars in urban neighborhoods in the United States.
|
J Stud Alcohol Drugs
|
2007
|
2.66
|
2
|
Evaluation of the mental health benefits of yoga in a secondary school: a preliminary randomized controlled trial.
|
J Behav Health Serv Res
|
2012
|
2.39
|
3
|
Rivaroxaban: can we trust the evidence?
|
BMJ
|
2016
|
2.14
|
4
|
Understanding healing relationships in primary care.
|
Ann Fam Med
|
2008
|
2.08
|
5
|
Why have UK doctors been deterred from prescribing Avastin?
|
BMJ
|
2015
|
1.96
|
6
|
Economic analysis of physical activity interventions.
|
Am J Prev Med
|
2011
|
1.66
|
7
|
Speaking of weight: how patients and primary care clinicians initiate weight loss counseling.
|
Prev Med
|
2004
|
1.64
|
8
|
Medical device recalls and transparency in the UK.
|
BMJ
|
2011
|
1.58
|
9
|
European drugs agency clashes with scientists over safety of GLP-1 drugs.
|
BMJ
|
2013
|
1.50
|
10
|
Rejecting political correctness.
|
BMJ
|
2005
|
1.47
|
11
|
Dabigatran: how the drug company withheld important analyses.
|
BMJ
|
2014
|
1.42
|
12
|
The neighborhood alcohol environment and alcohol-related morbidity.
|
Alcohol Alcohol
|
2009
|
1.41
|
13
|
How valid is the European Food Safety Authority's assessment of sports drinks?
|
BMJ
|
2012
|
1.40
|
14
|
Out and about: association of the built environment with physical activity behaviors of adolescent females.
|
Health Place
|
2011
|
1.37
|
15
|
Identifying walking trips from GPS and accelerometer data in adolescent females.
|
J Phys Act Health
|
2011
|
1.18
|
16
|
Etiological correlates of vaginismus: sexual and physical abuse, sexual knowledge, sexual self-schema, and relationship adjustment.
|
J Sex Marital Ther
|
2003
|
1.17
|
17
|
Quantifying the contribution of neighborhood parks to physical activity.
|
Prev Med
|
2013
|
1.15
|
18
|
What makes an orphan drug?
|
BMJ
|
2010
|
1.13
|
19
|
Multilevel spatio-temporal dual changepoint models for relating alcohol outlet destruction and changes in neighbourhood rates of assaultive violence.
|
Geospat Health
|
2008
|
1.12
|
20
|
Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus.
|
Arch Sex Behav
|
2004
|
1.12
|
21
|
The transcriptional repressor Mecp2 regulates terminal neuronal differentiation.
|
Mol Cell Neurosci
|
2004
|
1.07
|
22
|
Social capital and the neighborhood alcohol environment.
|
Health Place
|
2008
|
1.06
|
23
|
Determinants of social capital indicators at the neighborhood level: a longitudinal analysis of loss of off-sale alcohol outlets and voting.
|
J Stud Alcohol Drugs
|
2007
|
1.03
|
24
|
The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy.
|
Cancer
|
2004
|
1.03
|
25
|
Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care.
|
J Am Board Fam Med
|
2010
|
0.98
|
26
|
Use of qualitative methods and user-centered design to develop customized health information technology tools within federally qualified health centers to keep children insured.
|
J Ambul Care Manage
|
2014
|
0.96
|
27
|
Revision rates for metal on metal hip joints are double that of other materials.
|
BMJ
|
2011
|
0.95
|
28
|
Neighbourhood alcohol availability and gonorrhea rates: impact of social capital.
|
Geospat Health
|
2009
|
0.92
|
29
|
Insiders criticise FDA's decision not to withdraw rosiglitazone.
|
BMJ
|
2010
|
0.92
|
30
|
PSA testing: press coverage in UK and US is an ocean apart.
|
BMJ
|
2009
|
0.91
|
31
|
HIV/AIDS is spreading fastest in eastern Europe and Asia.
|
BMJ
|
2004
|
0.90
|
32
|
Impact of a new bicycle path on physical activity.
|
Prev Med
|
2007
|
0.88
|
33
|
The evidence underpinning sports performance products: a systematic assessment.
|
BMJ Open
|
2012
|
0.88
|
34
|
Will industry influence derail UN summit?
|
BMJ
|
2011
|
0.88
|
35
|
Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm.
|
BMJ
|
2013
|
0.87
|
36
|
Performance enhancement using a balanced scorecard in a Patient-centered Medical Home.
|
Fam Med
|
2011
|
0.86
|
37
|
Concerns over data in key dabigatran trial.
|
BMJ
|
2014
|
0.85
|
38
|
Examining role change in primary care practice.
|
J Prim Care Community Health
|
2012
|
0.84
|
39
|
Proximity to urban parks and mental health.
|
J Ment Health Policy Econ
|
2014
|
0.83
|
40
|
EMA consults public on plan to increase transparency of drug trial data.
|
BMJ
|
2013
|
0.82
|
41
|
FDA is to assess data linking type 2 diabetes drugs with pancreatitis.
|
BMJ
|
2013
|
0.81
|
42
|
Barrier in West Bank threatens residents' health care, says report.
|
BMJ
|
2005
|
0.81
|
43
|
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds.
|
BMJ
|
2013
|
0.80
|
44
|
Devices and desires: industry fights toughening of medical device regulation in Europe.
|
BMJ
|
2013
|
0.80
|
45
|
Hispanic concentration and the conditional influence of collective efficacy on adolescent childbearing.
|
Arch Pediatr Adolesc Med
|
2006
|
0.79
|
46
|
The Affordable Care Act's plan for consumer assistance with insurance moves states forward but remains a work in progress.
|
Health Aff (Millwood)
|
2013
|
0.79
|
47
|
Hyperplasia from GLP-1 drugs is "not a surprise," say researchers.
|
BMJ
|
2013
|
0.78
|
48
|
Investigations editor's reply to Holt and to Barnett and O'Hare.
|
BMJ
|
2013
|
0.78
|
49
|
Two drugs for type 2 diabetes seem to raise risk of acute pancreatitis, study shows.
|
BMJ
|
2013
|
0.77
|
50
|
Roche offers researchers access to all Tamiflu trials.
|
BMJ
|
2013
|
0.77
|
51
|
Questions remain over safety and effectiveness of oseltamivir.
|
BMJ
|
2012
|
0.77
|
52
|
Rebuilding from the rubble.
|
BMJ
|
2006
|
0.77
|
53
|
Asylum seekers in detention centres receive poor medical care, MP says.
|
BMJ
|
2008
|
0.77
|
54
|
NICE rules out NHS prescription of fingolimod for multiple sclerosis.
|
BMJ
|
2011
|
0.76
|
55
|
Patients are let down by poor device regulation, warn surgeons.
|
BMJ
|
2012
|
0.76
|
56
|
Questioning the timeline of H1N1 flu vaccination contracts.
|
Nature
|
2010
|
0.75
|
57
|
My six day experience in the Middle East.
|
BMJ
|
2005
|
0.75
|
58
|
Source of surgical instruments should be checked, BMA says.
|
BMJ
|
2008
|
0.75
|
59
|
WINDOW: wideband demodulator for optical waveforms.
|
Opt Express
|
2017
|
0.75
|
60
|
New obesity center at WVU offering comprehensive program..
|
W V Med J
|
2003
|
0.75
|
61
|
Manufacturer failed to disclose faulty device in rivaroxaban trial.
|
BMJ
|
2016
|
0.75
|
62
|
Medtronic submits full data on spinal protein to independent scrutiny.
|
BMJ
|
2011
|
0.75
|
63
|
European regulatory body recommends suspension of rosiglitazone.
|
BMJ
|
2010
|
0.75
|
64
|
US regulator seeks advice on health risks of metal on metal hip implants.
|
BMJ
|
2012
|
0.75
|
65
|
European Medicines Agency tightens rules on conflict of interest.
|
BMJ
|
2010
|
0.75
|
66
|
Study on metal-on-metal hip implants was halted a year before UK regulator banned their use.
|
BMJ
|
2012
|
0.75
|
67
|
Whistle while you work: an analysis of NHS foundation trust policies.
|
BMJ
|
2010
|
0.75
|
68
|
DePuy knew about hip implant's high failure rate three years before it was recalled.
|
BMJ
|
2013
|
0.75
|
69
|
Environmental groups criticise WHO plans to improve health.
|
BMJ
|
2004
|
0.75
|
70
|
FDA puts rosiglitazone post-marketing trial on hold.
|
BMJ
|
2010
|
0.75
|
71
|
Overhaul US licensing process for devices, urges Institute of Medicine.
|
BMJ
|
2011
|
0.75
|
72
|
Agency tells surgeons not to use a type of hip implant cup liner because of high revision rates.
|
BMJ
|
2012
|
0.75
|
73
|
Closing the vaccine gap among toddlers in N.J. family physicians' practices.
|
J Okla State Med Assoc
|
2005
|
0.75
|
74
|
Donor countries should ensure donated funds reach health workers.
|
BMJ
|
2007
|
0.75
|
75
|
Attacks on publicly funded trials: what happens when industry does not want to know the answer.
|
BMJ
|
2015
|
0.75
|
76
|
Support for tomorrow's doctors: getting it right, meeting their needs.
|
Occup Med (Lond)
|
2013
|
0.75
|
77
|
European Medicines Agency is to tighten up on advisers' conflicts of interest.
|
BMJ
|
2012
|
0.75
|
78
|
Drugs agency grants its first licence to homoeopathic product.
|
BMJ
|
2009
|
0.75
|
79
|
Blair pledges 150m pounds sterling to support and protect AIDS orphans.
|
BMJ
|
2004
|
0.75
|
80
|
Who was who? Race and Jews in turn-of-the-century Britain.
|
J Br Stud
|
2002
|
0.75
|
81
|
BMA meeting: Doctors urge government to lower age limit for cervical cancer screening.
|
BMJ
|
2009
|
0.75
|
82
|
UK health secretary promises to tighten regulatory procedures for medical devices.
|
BMJ
|
2012
|
0.75
|
83
|
Medical students should be added to GMC register, says judge.
|
BMJ
|
2005
|
0.75
|
84
|
Device licensing bodies sometimes put business before safety, an investigation finds.
|
BMJ
|
2012
|
0.75
|
85
|
MEP calls for tougher legislation to stop drug trials that could be considered as marketing.
|
BMJ
|
2012
|
0.75
|
86
|
Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration?
|
BMJ
|
2017
|
0.75
|
87
|
Providing nomadic people with health care.
|
BMJ
|
2005
|
0.75
|
88
|
Commitment to tackling alcohol misuse is missing from UN summit declaration, experts say.
|
BMJ
|
2011
|
0.75
|
89
|
Home care nurses: a study of the occurrence of culturally competent care.
|
J Transcult Nurs
|
2003
|
0.75
|
90
|
Cancer drugs: high price, uncertain value.
|
BMJ
|
2017
|
0.75
|